BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $550K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

45% less capital invested

Capital invested by funds: $992K → $550K (-$442K)

83% less call options, than puts

Call options by funds: $4K | Put options by funds: $23K

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
$23K
Net Calls
Net Calls Change

Top Buyers

1
+$271K
2
+$4.83K
3
+$3.67K

Top Sellers

1
-$259K
2
-$223K
3
-$97.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$271K
2
$181K
3
$85.3K
4
$5.85K
5
$4.93K
6
$1.54K
7
–